Guidelines for the diagnosis and treatment of depressive disorders in China: The second edition

被引:24
作者
Feng, Yuan [1 ,2 ,3 ]
Xiao, Le [1 ,2 ,3 ]
Wang, Wei-Wei [1 ,2 ,3 ]
Ungvari, Gabor S. [4 ,5 ]
Ng, Chee H. [6 ]
Wang, Gang [1 ,2 ,3 ]
Xiang, Yu-Tao [7 ]
机构
[1] Capital Med Univ, Sch Mental Hlth, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China
[2] Capital Med Univ, Sch Mental Hlth, Beijing Key Lab Mental Disorders, Beijing Anding Hosp, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Sch Mental Hlth, Beijing, Peoples R China
[4] Univ Notre Dame Australia, Fremantle, WA, Australia
[5] Univ Western Australia, Sch Med, Div Psychiat, Perth, WA, Australia
[6] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia
[7] Univ Macau, Fac Hlth Sci, Inst Translat Med, Unit Psychiat, Macau, Peoples R China
关键词
Depressive disorders; Diagnosis; Treatment; China; Treatment guidelines; SEROTONIN REUPTAKE INHIBITOR; ANXIETY TREATMENTS CANMAT; MENTAL-DISORDERS; CANADIAN NETWORK; DOUBLE-BLIND; ANTIDEPRESSANTS; METAANALYSIS; PLACEBO; AUGMENTATION; EFFICACY;
D O I
10.1016/j.jad.2019.04.104
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The recent guidelines for depressive disorders in China are based on both the first edition published in 2003, and new scientific evidence reviewed until the end of 2014. The purpose of the guidelines is to provide a comprehensive overview of the scientific evidence for the diagnosis and treatment of depressive disorders for Chinese patients. Methods: The data used in the guidelines were extracted from the recent literature, and various international treatment guidelines. Results: The current (second) guidelines are based on both evidence-based and measurement-based approaches. Comprehensive and regular assessments with standard instruments are recommended in the acute, continuation, and maintenance treatment phases, and the stage prior to the termination of treatment. In order to reduce the risk of relapse, the new guidelines are extended to the entire course of treatment. Recommendations for pharmacotherapeutic and other treatment modalities are described in detail. Conclusions: Although major advances have been made compared to the 2003 edition of the guidelines, more intensive research is needed to optimize diagnosis and treatment of depressive disorders in China. The new guidelines provide only recommendations for diagnosis and treatment, therefore clinicians should develop individualized treatment plans along the lines of the comprehensive information obtained from patients and their families.
引用
收藏
页码:352 / 356
页数:5
相关论文
共 51 条
[51]   How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low [J].
Zimmerman, Mark ;
Thongy, Tavi .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (08) :1271-1276